Stockholm, Sweden

Joakim Dillner


Average Co-Inventor Count = 2.3

ph-index = 4

Forward Citations = 59(Granted Patents)


Location History:

  • Stockholm, SE (1993 - 1999)
  • Danderyd, SE (1999)

Company Filing History:


Years Active: 1993-1999

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Joakim Dillner: Innovator in Papillomavirus Research

Introduction

Joakim Dillner is a prominent inventor based in Stockholm, Sweden. He has made significant contributions to the field of medical research, particularly in the area of papillomavirus infections. With a total of six patents to his name, Dillner's work has had a substantial impact on diagnostics and treatment methods.

Latest Patents

One of Dillner's latest patents is a peptide-based composition aimed at combating papillomavirus infections. This invention focuses on synthetic peptides related to human papillomaviruses, specifically types 1, 5, 6, 8, 11, 16, 18, and 31. The patent describes a method for diagnosing the presence of papillomavirus infections, particularly those associated with cervical cancer and condyloma. This method involves the detection of virus-specific antigen-antibody complexes through immunoassays, showcasing Dillner's innovative approach to addressing serious health issues.

Career Highlights

Throughout his career, Joakim Dillner has worked with esteemed organizations such as The Scripps Research Institute and Euro-Diagnostica AB. His experience in these institutions has allowed him to develop and refine his research, leading to groundbreaking inventions in the field of virology.

Collaborations

Dillner has collaborated with notable colleagues, including Richard A. Lerner and Richard S. Smith. These partnerships have further enhanced his research capabilities and contributed to the advancement of knowledge in papillomavirus studies.

Conclusion

Joakim Dillner's contributions to the field of papillomavirus research through his innovative patents and collaborations highlight his role as a leading inventor. His work continues to pave the way for improved diagnostic methods and treatments for papillomavirus infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…